연구성과로 돌아가기
2025 연구자 정보 (363 / 657)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Bang, Soo-Mee (Bang, SM) |
Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea |
|
|
[JCR상위 23.5] Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study | SCIE | 23.5 | ONCOLOGY | lee86@catholic.ac.kr; | ||
|
Cheong, June-Won (Cheong, JW) |
Yonsei Univ, Coll Med, Severance Hosp,Dept Internal Med, Div Hematol, Seoul, South Korea |
|
|
[JCR상위 23.5] Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study | SCIE | 23.5 | ONCOLOGY | lee86@catholic.ac.kr; | ||
|
Choi, Chul Won (Choi, CW) |
Korea Univ, Guro Hosp, Div Oncol & Hematol, Dept Internal Med, Seoul, South Korea |
|
|
[JCR상위 23.5] Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study | SCIE | 23.5 | ONCOLOGY | lee86@catholic.ac.kr; | ||
|
Choi, Eun-Ji (Choi, EJ) |
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea |
|
|
[JCR상위 23.5] Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study | SCIE | 23.5 | ONCOLOGY | lee86@catholic.ac.kr; | ||
|
Lee, Gyeong-Won (Lee, GW) |
Gyeongsang Natl Univ, Coll Med, Gyeongsang Natl Univ Hosp,Inst Hlth Sci, Div Hematol & Oncol,Dept Internal Med, Jinju, South Korea |
|
|
[JCR상위 23.5] Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study | SCIE | 23.5 | ONCOLOGY | lee86@catholic.ac.kr; | ||
|
Oh, Suk Joong (Oh, SJ) |
Hanyang Univ, Dept Oncol, Asan Med Ctr, Seoul 138736, South Korea |
|
|
[JCR상위 23.5] Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study | SCIE | 23.5 | ONCOLOGY | lee86@catholic.ac.kr; | ||
|
Park, Joon Seong (Park, JS) |
Ajou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea |
|
|
[JCR상위 23.5] Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study | SCIE | 23.5 | ONCOLOGY | lee86@catholic.ac.kr; | ||
|
Park, Yong (Park, Y) |
Korea Univ, Coll Med, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea |
|
|
[JCR상위 23.5] Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study | SCIE | 23.5 | ONCOLOGY | lee86@catholic.ac.kr; | ||
|
Park, Young Hoon (Park, YH) |
Ewha Womans Univ, Mokdong Hosp, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea |
MBG-1896-2025 Park, Young Sik |
|
[JCR상위 23.5] Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
SCIE ESCI |
23.5 |
ONCOLOGY HEMATOLOGY |
lee86@catholic.ac.kr; kihyunkimk@gmail.com; |
||
|
Yoon, Seug Yun (Yoon, SY) |
제1저자 | Soonchunhyang Univ, Seoul Hosp, Dept Internal Med, Div Hematol & Med Oncol, Seoul, South Korea |
|
|
[JCR상위 23.5] Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study | SCIE | 23.5 | ONCOLOGY | lee86@catholic.ac.kr; | |
|
Choi, Keum-Ju (Choi, KJ) |
Daegu Catholic Univ, Coll Med, Dept Internal Med, Daegu, South Korea |
|
|
[JCR상위 23.6] Factors predicting early recurrence in patients with unresectable stage III non-small cell lung cancer on durvalumab consolidation after chemoradiotherapy | SCIE | 23.6 | ONCOLOGY;RESPIRATORY SYSTEM | fireajh@gmail.com; | ||
|
Hong, Kyung Soo (Hong, KS) |
Yeungnam Univ, Coll Med, Dept Internal Med, 170 Hyeonchung Ro, Daegu 42415, South Korea |
|
|
[JCR상위 23.6] Factors predicting early recurrence in patients with unresectable stage III non-small cell lung cancer on durvalumab consolidation after chemoradiotherapy | SCIE | 23.6 | ONCOLOGY;RESPIRATORY SYSTEM | fireajh@gmail.com; | ||
|
Jang, Jong Geol (Jang, JG) |
Yeungnam Univ, Coll Med, Dept Internal Med, 170 Hyeonchung Ro, Daegu 42415, South Korea |
|
|
[JCR상위 23.6] Factors predicting early recurrence in patients with unresectable stage III non-small cell lung cancer on durvalumab consolidation after chemoradiotherapy | SCIE | 23.6 | ONCOLOGY;RESPIRATORY SYSTEM | fireajh@gmail.com; | ||
|
Kim, Chanmi (Kim, C) |
Yonsei Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea Yeungnam Univ, Coll Med, Dept Internal Med, 170 Hyeonchung Ro, Daegu 42415, South Korea |
|
|
[JCR상위 23.6] Factors predicting early recurrence in patients with unresectable stage III non-small cell lung cancer on durvalumab consolidation after chemoradiotherapy | SCIE | 23.6 | ONCOLOGY;RESPIRATORY SYSTEM | fireajh@gmail.com; | ||
|
Kim, Jehun (Kim, J) |
Kosin Univ, Coll Med, Dept Internal Med, Busan, South Korea |
|
|
[JCR상위 23.6] Factors predicting early recurrence in patients with unresectable stage III non-small cell lung cancer on durvalumab consolidation after chemoradiotherapy | SCIE | 23.6 | ONCOLOGY;RESPIRATORY SYSTEM | fireajh@gmail.com; |
페이지 이동: